Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles
- 14 January 2004
- journal article
- research article
- Published by Elsevier
- Vol. 14 (4) , 953-957
- https://doi.org/10.1016/j.bmcl.2003.12.002
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pancreatic cancer biology and geneticsNature Reviews Cancer, 2002
- Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic AnalysisJournal of Medicinal Chemistry, 2001
- Expression of Nerve Growth Factors in Pancreatic Neural Tissue and Pancreatic CancerJournal of Histochemistry & Cytochemistry, 2001
- Identification of Substituted 3-[(4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene]- 1,3-dihydroindol-2-ones as Growth Factor Receptor Inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ Tyrosine KinasesJournal of Medicinal Chemistry, 2000
- Expression of p75LNGFR and Trk neurotrophin receptors in normal and neoplastic human prostateBJU International, 1999
- Development and Uses of Small Molecule Ligands of TrkA ReceptorsPublished by Springer Nature ,1998
- Kinetics of trkA Tyrosine Kinase Activity and Inhibition by K-252aArchives of Biochemistry and Biophysics, 1998
- Signal transduction by the neutrophin receptorsCurrent Opinion in Cell Biology, 1997
- Formylation of phenols with electron-withdrawing groups in strong acids. Synthesis of substituted salicylaldehydes.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- β,β-Diacyl-enamines and -enoles, III Formylation of CH2-acidic Compounds via the Anilinomethylene DerivativesZeitschrift für Naturforschung B, 1979